[Clinical studies with a new tocolytic agent (Th 1165 a). Contribution to the management of threatening premature labor].
D000022:Abortion, Spontaneous / Q000517:prevention & control; D001034:Apgar Score; D001794:Blood Pressure; D005260:Female; D005318:Fetal Heart; D006339:Heart Rate; D006801:Humans; D007022:Hypotension / Q000139:chemically induced; D007231:Infant, Newborn; D007234:Infant, Premature; D007275:Injections, Intravenous; D009921:Metaproterenol / Q000008:administration & dosage / Q000009:adverse effects / Q000627:therapeutic use*; D007752:Obstetric Labor, Premature / Q000188:drug therapy* / Q000517:prevention & control; D010636:Phenols / Q000008:administration & dosage / Q000009:adverse effects / Q000627:therapeutic use; D011247:Pregnancy; D011674:Pulse
D010636:Phenols; D009921:Metaproterenol
Klinische Untersuchungen mit einem neuen Tokolytikum (Th 1165a). Ein Beitrag zur Behandlung der drohenden Frühgeburt.